Vertex Pharmaceuticals Incorporated
Pteridinone compounds and uses thereof

Last updated:

Abstract:

The present invention provides compounds of Formula I, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).

Status:
Grant
Type:

Utility

Filling date:

23 Apr 2019

Issue date:

13 Jul 2021